Answers are grounded in this paper and cite their sources.
Infrainguinal bypass using greater saphenous vein have excellent results, but options become varied in the absence of full-length saphenous vein. The purpose of this study is to evaluate outcomes in tibial bypasses with autogenous, prosthetic, and cryopreserved conduit. Retrospective review of vascular surgery management database was queried for tibial outflow bypasses between 6/1/23 and 6/30/23. Indications, demographics, operative details, and outcomes were recorded and compared using standard statistical methods. A total of 2314 bypasses were performed, of which 981 were in situ (ISB), 930 excised vein (VEIN), 246 spliced vein (SPLC), 126 PTFE (PTFE), and 31 cryopreserved artery/vein (CRYO). Mean age was 69 years (range, 14-96 years), and 1636 (70.7%) were male with no sex difference between groups (P = .214). Comorbidities were similar except for more hypertension in CRYO and SPLC (P < .001) and more diabetes in CRYO (P < .001). Indications demonstrated more claudication in ISB (108; 11.1% ISB vs 53; 5.7% VEIN vs 8; 3.2% SPLC vs 0; 0% PTFE vs 1; 3.2% CRYO; P < .001) and more tissue loss in CRYO (18; 58.0% CRYO vs 550; 56.0% ISB vs 414; 44.5% VEIN vs 123; 49.9% SPLC vs 60; 47.6% PTFE; P < .001). Outflow artery was significantly different: ISB/VEIN/PTFE favored posterior tibial (512; 52.2% ISB vs 408; 43.8% VEIN vs 52; 41.3% PTFE) and CRYO favored anterior tibial (14; 45.2%; P < .001). Complications were similar for bleeding (P = .816), infection (P = .695), and cardiac (P = .052). Higher 30-day admission rates were seen for CRYO and SPLC (4; 12.9% vs 32; 13.0%; P = .04) and PTFE had higher rates of graft occlusion (12; 9.5%; P = .04). Perioperative death rates were highest in CRYO (2; 6.9% CRYO vs 6; 4.76% PTFE vs 9; 3.7% SPLC vs 33; 3.6% VEIN vs 15; 1.5% ISB; P = .02). Thirty-day major amputation rates were highest in PTFE (14; 11.1% PTFE vs 1; 3.2% CRYO vs 8; 3.3% SPLC vs 34; 3.7% VEIN vs 22; 2.2% ISB; P < .001). Late amputation rates were higher in PTFE (17; 13.3% PTFE vs 2; 6.5% CRYO vs 12; 4.9% SPLC vs 31; 2.2% VEIN vs 23; 2.3% ISB; P < .001). Ipsilateral saphenous vein remains the standard for tibial artery bypasses; however, excised vein and spliced vein offer reasonable amputation-free survival. PTFE or cryopreserved homograft for tibial bypass is an option in the absence of autogenous conduit, but with higher occlusion and amputation rates.
No takes yet. Share an insight, caveat, or question.
Hnath et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: